Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

<p>Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus</p>
Zheng Quan Toh, Jennie Kosasih, Fiona M. Russell, et al.
Infection and Drug Resistance (2019) Vol. Volume 12, pp. 1951-1967
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer
Supitcha Kamolratanakul, Punnee Pitisuttithum
Vaccines (2021) Vol. 9, Iss. 12, pp. 1413-1413
Open Access | Times Cited: 161
Advances in Infectious Disease Vaccine Adjuvants
Jingyi Fan, Shengbin Jin, Lachlan Gilmartin, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1120-1120
Open Access | Times Cited: 71
Current and future direction in treatment of HPV-related cervical disease
Niloofar Khairkhah, Azam Bolhassani, Reza Najafipour
Journal of Molecular Medicine (2022) Vol. 100, Iss. 6, pp. 829-845
Open Access | Times Cited: 54
Engineering Saccharomyces cerevisiae for medical applications
Carla Maneira, Alexandre Chamas, Gerald Lackner
Microbial Cell Factories (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Investigation on Spontaneous Abortion and Human Papillomavirus Infection
Mauro Tognon, Andrea Tagliapietra, Federica Magagnoli, et al.
Vaccines (2020) Vol. 8, Iss. 3, pp. 473-473
Open Access | Times Cited: 54
HPV and Recurrent Respiratory Papillomatosis: A Brief Review
Amr Ouda, Ahmed Elsabagh, Ibrahim Elmakaty, et al.
Life (2021) Vol. 11, Iss. 11, pp. 1279-1279
Open Access | Times Cited: 46
Systems serology analysis shows IgG1 and IgG3 memory responses six years after one dose of quadrivalent HPV vaccine
Chau Quang, J. L. Anderson, Fiona M. Russell, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Human papillomavirus genotype distribution among women with and without cervical cancer: Implication for vaccination and screening in Ghana
Yvonne Nartey, Kwabena Amo‐Antwi, Philip C. Hill, et al.
PLoS ONE (2023) Vol. 18, Iss. 1, pp. e0280437-e0280437
Open Access | Times Cited: 12
Burden and Prevention of HPV. Knowledge, Practices and Attitude Assessment Among Pre-Adolescents and their Parents in Italy
Giancarlo Icardi, Claudio Costantino, Marcello Guido, et al.
Current Pharmaceutical Design (2020) Vol. 26, Iss. 3, pp. 326-342
Open Access | Times Cited: 29
Human Papillomaviruses-Related Cancers: An Update on the Presence and Prevention Strategies in the Middle East and North African Regions
Queenie Fernandes, Soumaya Allouch, Ishita Gupta, et al.
Pathogens (2022) Vol. 11, Iss. 11, pp. 1380-1380
Open Access | Times Cited: 16
Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine
Xu Zhou, Lihua Sun, Xiaoxiao Yao, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 24
HPV-Specific Systemic Antibody Responses and Memory B Cells are Independently Maintained up to 6 Years and in a Vaccine-Specific Manner Following Immunization with Cervarix and Gardasil in Adolescent and Young Adult Women in Vaccination Programs in Italy
Francesco Nicoli, Barbara Mantelli, Eleonora Gallerani, et al.
Vaccines (2020) Vol. 8, Iss. 1, pp. 26-26
Open Access | Times Cited: 21
The nonavalent vaccine: a review of high-risk HPVs and a plea to the CDC.
Ariel Yusupov, Daniel Popovsky, Lyaba Mahmood, et al.
PubMed (2019) Vol. 8, Iss. 3, pp. 52-64
Closed Access | Times Cited: 20
Cervical Cancer Prevention in Low- and Middle-Income Countries
Emma Allanson, Kathleen M. Schmeler
Clinical Obstetrics & Gynecology (2021) Vol. 64, Iss. 3, pp. 501-518
Open Access | Times Cited: 17
Antibodies to Crucial Epitopes on HSV-2 Glycoprotein D as a Guide to Dosing an mRNA Genital Herpes Vaccine
Lauren M. Hook, Sita Awasthi, Tina M. Cairns, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 540-540
Open Access | Times Cited: 12
Nanotechnology based vaccines: Cervical cancer management and perspectives
Ridhima Jasrotia, Daljeet Singh Dhanjal, Sonali Bhardwaj, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 71, pp. 103351-103351
Closed Access | Times Cited: 12
A nationwide longitudinal study on risk factors for progression of anal intraepithelial neoplasia grade 3 to anal cancer
Mette Tuxen Faber, Kirsten Frederiksen, Joel M. Palefsky, et al.
International Journal of Cancer (2022) Vol. 151, Iss. 8, pp. 1240-1247
Open Access | Times Cited: 12
Stakeholder Perspectives of Australia’s National HPV Vaccination Program
Caitlin Swift, Aditi Dey, Harunor Rashid, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1976-1976
Open Access | Times Cited: 11
Role of HPV vaccination for prevention of male infertility
Francesco Muscianisi, Carlo Foresta, Andrea Garolla
Minerva Endocrinology (2022) Vol. 47, Iss. 1
Closed Access | Times Cited: 10
Adverse events from HPV vaccination in Taiwan
S P Tsai, Chun‐Yi Lu, Tzu-I Chen, et al.
Vaccine (2023) Vol. 41, Iss. 49, pp. 7444-7449
Open Access | Times Cited: 5
Genetic and Epigenetic Variations of HPV52 in Cervical Precancer
Katharine J. Bee, Ana Gradíssimo, Zigui Chen, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6463-6463
Open Access | Times Cited: 12
Preventing Cervical Cancer Globally: Are We Making Progress?
Emma Allanson, Kathleen M. Schmeler
Cancer Prevention Research (2021) Vol. 14, Iss. 12, pp. 1055-1060
Open Access | Times Cited: 11
The crossroads: divergent roles of virus‐specific CD4+ T lymphocytes in determining the outcome for human papillomavirus infection
David van Bockel, Anthony D. Kelleher
Immunology and Cell Biology (2023) Vol. 101, Iss. 6, pp. 525-534
Open Access | Times Cited: 4
Challenges of hesitancy in human papillomavirus vaccination: Bibliometric and visual analysis
Disi Deng, Yifeng Shen, Wanjing Li, et al.
The International Journal of Health Planning and Management (2023) Vol. 38, Iss. 5, pp. 1161-1183
Open Access | Times Cited: 4
Human Papillomavirus (HPV) Vaccine Knowledge, Awareness and Acceptance among Dental Students and Post-Graduate Dental Residents
Steven Mann, Karl Kingsley
Dentistry Journal (2020) Vol. 8, Iss. 2, pp. 45-45
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top